IMBIZO RESEARCH STUDY | |||||
Study Phase (recruitment dates) | 18–24 years | 25–49 years | Prevalence Ratio comparing Phase 2 to Phase 1 (25–49 years) | ||
PR (95% CI) | p-value | ||||
Phase 1 (01 Apr 2014–30 Sep 2014) N = 1597 | n (%) | 720 (45.1) | 877 (54.9) | 1 | 0.019 |
Phase 2 (22 Jun −30 Nov 2015) N = 1216 | n (%) | 494 (40.6) | 722 (59.4) | 1.08 (1.01–1.15) | |
MMC ROUTINE DATA | |||||
Routine data (dates coinciding with Phase recruitment) | 18–24 years | 25–49 years | Prevalence Ratio comparing Phase 2 to Phase 1 (25–49 years) | ||
Phase 1 (01 Apr 2014–30 Sep 2014) N = 9169 | n (%) | 4295 (46.8) | 4874 (53.2) | 1 | < 0.001 |
Phase 2 (22 Jun 2015–30 Nov 2015) N = 4839 | n (%) | 2089 (43.2) | 2750 (56.8) | 1.07 (1.04–1.10) |